STIRLING PRODUCTS LIMITED
STI - 2007 Annual General Meeting - Dr Calvin London, MD
Fri, 23 Nov 2007 12:00PM
Click to listen to audio on your default player or
Download the latest version of the Flash Player
Dr Calvin London
Fri, 23 Nov 2007
12:00PM Australia/NSW
Select a tab above to display more information
STIRLING PRODUCTS LIMITED (STI)
ASX code: STI
Website:
Industry: Pharmaceuticals, Biotechnology & Life Sciences
Principal Activities:
Commercialising patented beta agonist Repartitioning Feed Enhancers ('RFEs') for livestock, which are being positioned as replacement products and alternatives to the use of antibiotics and hormones as growth promoters.
Address:
, 275 George Street, Level 1,
SYDNEY
NSW
Phone: 02 9299 9270
Fax: 02 9299 9276
Executives & Directors
Prof. Clive P Page , Non Exec. Chairman, Non Exec. Director
Mr Peter Boonen , Managing Director, Executive Director
Dr Calvin London , Managing Director
Mr Gulshan Jugroo , Director, CFO
Mr George Karantzias , Non Exec. Director
Mr Gulshan Jugroo , Company Secretary
Company Podcasts
Company ASX Announcements
Company ASX announcements can be viewed on the ASX website.
Announcements from the preceding six months are shown below.
Please refer to the relevant stock exchange if any of the above information is incorrect
STIRLING PRODUCTS LIMITED (STI) Events
| Company (Stock Code) | Date/Time | Event |
Timezone: |
|---|---|---|---|
|
Wed, 6 Aug 2008 11:30AM |
STI - Shareholder Update 2nd Quarter 2008 - Dr Calvin London, MD |
![]() |
|
Wed, 23 Apr 2008 04:00PM |
Excellence in Biotechnology Investment - Dr Calvin London, MD, Stirling Products Ltd |
![]() |
|
Tue, 22 Apr 2008 10:30AM |
STI - Shareholder Update 1st Quarter 2008 - Dr Calvin London, MD |
![]() |
|
Fri, 23 Nov 2007 12:00PM |
STI - 2007 Annual General Meeting - Dr Calvin London, MD |
![]() |
|
Fri, 12 Oct 2007 05:00PM |
STI - Activities Update - Dr Calvin London, MD |
![]() |
|
Tue, 31 Jul 2007 10:00AM |
STI - Activities Update - Dr Calvin London, MD |
![]() |
|
Tue, 24 Apr 2007 02:00PM |
STI - First Quarter CY 2007 Market Update - Dr Calvin London, MD |
![]() |
|
Wed, 7 Feb 2007 11:00AM |
STI - Agreement Signed with North American Bioscience Company - Dr Calvin London, MD |
![]() |
|
Thu, 23 Nov 2006 08:30AM |
STI - Annual General Meeting - Dr Calvin London CEO |
![]() |
|
Tue, 10 Oct 2006 11:00AM |
STI - Update on the Commencement of Several Trials - Dr Calvin London, MD and CEO |
![]() |
|
Mon, 28 Aug 2006 04:00PM |
STI - R-Salbutamol Adds Substantial Weight Gain to Lambs - Dr Calvin London, Managing Director |
![]() |
|
Mon, 17 Jul 2006 03:00PM |
STI - European Joint Venture - Dr Calvin London, MD & CEO |
![]() |
|
Fri, 26 May 2006 10:30AM |
STI - Animal Growth Promoters - Dr Calvin London, Managing Director and CEO |
![]() |
| Thu, 26 Feb 2009 11:00PM |
Interim Results | ||
| Fri, 21 Nov 2008 12:00PM 02:00AM Australia/WA |
Annual General Meeting Plaza Level, BGC Centre, 28 The Esplanade, Perth, WA
|
||
| Mon, 20 Oct 2008 11:00PM |
Full Year Results | ||
| Fri, 23 Nov 2007 09:00AM |
Annual General Meeting BGC Centre, 28 The Esplanade Perth WA
|
||
| Wed, 29 Aug 2007 | Full Year Results | ||
| Thu, 22 Feb 2007 11:00PM |
Interim Results | ||
| Wed, 22 Nov 2006 10:00AM |
Annual General Meeting Mezzanine Level, BGC Centre, 28 The Esplinade Perth WA
|
||
| Fri, 8 Sep 2006 | Full Year Results | ||
| Thu, 30 Mar 2006 11:00PM |
Date Payable | ||
| Wed, 15 Mar 2006 11:00PM |
Interim Results | ||
| Thu, 24 Nov 2005 09:00AM 11:00PM Australia/WA |
Annual General Meeting | ||
|
|
|||
STIRLING PRODUCTS LIMITED (STI)
| Appendix 3B | Thu, 2 Jul 2009 |
| Change of Director`s Interest Notice | Wed, 1 Jul 2009 |
| Pharmaceutical Business Acquisition in Process | Fri, 26 Jun 2009 |
| Becoming a substantial holder | Fri, 26 Jun 2009 |
| Appendix 3B | Fri, 26 Jun 2009 |
| Trading Halt | Wed, 24 Jun 2009 |
| Product Sales Progress | Mon, 22 Jun 2009 |
| Appendix 3B | Fri, 19 Jun 2009 |
| Appendix 3B | Fri, 12 Jun 2009 |
| Distribution and Product Sale Agreement - Mexico | Wed, 10 Jun 2009 |
Please note: This company appears on this website as a result of its listing on the Australian Securities Exchange. Boardroom Radio does not claim any association with any company listed on this site.






















